Related news and events
Infleqtion to Go Public Through Merger With Churchill Capital Corp X
Experience
CalypsoAI to Be Acquired by F5
September 17, 2025
Cooley advised CalypsoAI, an adaptive artificial intelligence security platform that empowers enterprises to innovate safely, on its acquisition by F5, a global leader in delivering and securing every app and application programming interface.
Related contacts
Related Practices & Industries
Infleqtion to Go Public Through Merger With Churchill Capital Corp X
September 8, 2025
Cooley advised Infleqtion, a global leader in neutral atom-based quantum technology, on its definitive business combination agreement with Churchill Capital Corp X, with the aim to accelerate Infleqtion’s mission to commercialize quantum products that provide orders of magnitude improvement in computing and precision sensing applications.
Related contacts
Related Practices & Industries
Capstan Therapeutics Announces up to $2.1 Billion Acquisition by AbbVie
June 30, 2025
Cooley advised Capstan Therapeutics, a clinical-stage biotechnology company with a mission to multiply therapeutic possibilities for patients through targeted in vivo RNA technologies, on its definitive agreement to be acquired by AbbVie.
Related contacts
Related Practices & Industries
Rhino.ai Announces $50 Million Series A
February 6, 2025
Cooley represented Rhino.ai, an artificial intelligence-powered enterprise platform, in its $50 million Series A preferred stock financing.
Related contacts
Related Practices & Industries
Admissions and credentials
Virginia
District of Columbia
New York